Catalog ID
PS-LIRA
Peptide Sciences Liraglutide
GLP-1 receptor agonist (liraglutide)
Peptide Sciences Liraglutide — a synthetic long-acting GLP-1 receptor agonist investigated in weight-management and metabolic research for effects on appetite regulation, energy intake, glucose-dependent insulin secretion and adiposity in preclinical and clinical models.
Molecular Formula
C215H348N56O65 (reported)
Formula reported for liraglutide; not independently verified for this preparation.
Purity
99.2%
Molecular Weight
3751.96 g/mol (reported)
Classification
GLP-1 receptor agonist / incretin mimetic
Price
$220.00 – $680.00 USD
Indicative range · converted from USD · free shipping from €500
Pricing tiers · mass & purity
5mg
$220.00
99.2%
10mg
$400.00
99.2%
30mg
$680.00
99.2%
Scientific Background
Liraglutide is a synthetic long-acting GLP-1 receptor agonist derived from human glucagon-like peptide-1, modified for prolonged duration of action. Research examines its effects on appetite regulation, energy intake and glucose-dependent insulin secretion in metabolic and weight-management models.
Research Focus — Pathways
GLP-1 receptor signaling; cAMP-mediated insulin secretion; central appetite regulation.
Research Areas
- GLP-1 receptor agonism
- Appetite signaling
- Energy intake regulation
- Glucose-dependent insulin secretion
- Adiposity research
Molecular Formula
C215H348N56O65 (reported)
Formula reported for liraglutide; not independently verified for this preparation.
Molecular Weight
3751.96 g/mol (reported)
Molecular weight reported for liraglutide; not independently verified for this preparation.
Amino Acid Sequence
HAibEGTFTSDVSSYLEGQAAKEFIAWLVRGRG (liraglutide, modified GLP-1 analogue)
Classification
GLP-1 receptor agonist / incretin mimetic
Research Format
Lyophilized research reagent
Purity
99.2%
Peptide Classification
GLP-1 receptor agonist / incretin mimetic
Sequence Notation
HAibEGTFTSDVSSYLEGQAAKEFIAWLVRGRG (liraglutide, modified GLP-1 analogue)
Scientific References
The following authoritative sources provide peer-reviewed literature on Peptide Sciences Liraglutide. Peptide Hub Biotech World Wide does not claim these sources endorse this product.
Liraglutide — PubMed literature
PubMed / NCBI
https://pubmed.ncbi.nlm.nih.gov/?term=liraglutideGLP-1 receptor agonists review
PubMed / NCBI
https://pubmed.ncbi.nlm.nih.gov/?term=GLP-1+receptor+agonist+review
Peptide Sciences Liraglutide — frequently asked
What is Peptide Sciences Liraglutide used for in research?
Peptide Sciences Liraglutide (GLP-1 receptor agonist (liraglutide)) is investigated in glp-1 receptor agonism, appetite signaling, energy intake regulation, glucose-dependent insulin secretion, adiposity research research. Liraglutide is a synthetic long-acting GLP-1 receptor agonist derived from human glucagon-like peptide-1, modified for prolonged duration of action. Research examines its effects on appetite regulation, energy intake and glucose-dependent insulin secretion in metabolic and weight-management models.
What purity and documentation does Peptide Sciences Liraglutide include?
Peptide Sciences Liraglutide is supplied at 99.2% reported purity as a Lyophilized research reagent. A Certificate of Analysis (COA) is available on request with every order.
Does Peptide Hub Biotech World Wide ship Peptide Sciences Liraglutide to the USA, Canada, Europe, Australia and New Zealand?
Yes. Peptide Hub Biotech World Wide ships Peptide Sciences Liraglutide to research customers in the United States, Canada, across Europe, Australia, New Zealand and South American markets. Bulk and wholesale quotes are available via the contact form.
How can I order Peptide Sciences Liraglutide?
Order directly from each product page via our Bitcoin (BTC) checkout — there is no minimum order, and shipping is free on orders from €500 (converted to your local currency). For bulk or wholesale quantities, request a quote through the contact form. After payment, confirm your transaction by email and shipping will proceed.
Related Products
NEWWeight Management99.2%Peptide Sciences Semaglutide
GLP-1 receptor agonist studied in appetite regulation, glucose-dependent insulin secretion and adiposity research.
NEWWeight Management99.3%Peptide Sciences Tirzepatide
Dual GIP and GLP-1 receptor agonist studied in adiposity, appetite regulation and energy-balance research.
NEWWeight Management99.1%Peptide Sciences Cagrlintide
Amylin and calcitonin receptor agonist studied in appetite suppression and adiposity research.
QC & Quality Systems
Every lot is verified by HPLC and mass-spectrometry purity analysis, peptide-content determination and residual-solvent testing, with a Certificate of Analysis issued per batch — aligned to ISO 9001:2015 and ISO 13485:2016 quality systems, with FDA Drug Master File (DMF) and MDSAP regulatory pathways supported.
ISO 9001:2015
Quality Management System
ISO 13485:2016
Medical Device QMS
FDA DMF
Drug Master File
MDSAP
Medical Device Single Audit Program
Quality & Documentation
Certificate of Analysis available on request · Research Use Only
Request a Quote